- Home
- DOMO vs CADL Comparison
DOMO vs CADL Comparison
Compare DOMO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- CADL
- Stock Information
- Founded
- DOMO 2010
- CADL 1999
- Country
- DOMO United States
- CADL United States
- Employees
- DOMO 958
- CADL N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- DOMO Technology
- CADL Health Care
- Exchange
- DOMO Nasdaq
- CADL Nasdaq
- Market Cap
- DOMO 324.2M
- CADL 306.4M
- IPO Year
- DOMO 2018
- CADL 2021
- Fundamental
- Price
- DOMO $8.20
- CADL $8.38
- Analyst Decision
- DOMO Hold
- CADL Strong Buy
- Analyst Count
- DOMO 6
- CADL 4
- Target Price
- DOMO $10.42
- CADL $21.00
- AVG Volume (30 Days)
- DOMO 339.8K
- CADL 1.2M
- Earning Date
- DOMO 03-06-2025
- CADL 03-13-2025
- Dividend Yield
- DOMO N/A
- CADL N/A
- EPS Growth
- DOMO N/A
- CADL N/A
- EPS
- DOMO N/A
- CADL N/A
- Revenue
- DOMO $317,044,000.00
- CADL N/A
- Revenue This Year
- DOMO $0.86
- CADL N/A
- Revenue Next Year
- DOMO $1.94
- CADL N/A
- P/E Ratio
- DOMO N/A
- CADL N/A
- Revenue Growth
- DOMO N/A
- CADL N/A
- 52 Week Low
- DOMO $6.11
- CADL $1.40
- 52 Week High
- DOMO $10.15
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- DOMO 50.52
- CADL 48.83
- Support Level
- DOMO $8.05
- CADL $8.13
- Resistance Level
- DOMO $8.76
- CADL $9.08
- Average True Range (ATR)
- DOMO 0.47
- CADL 0.57
- MACD
- DOMO 0.03
- CADL -0.02
- Stochastic Oscillator
- DOMO 68.18
- CADL 60.67
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.